Please use this identifier to cite or link to this item:
http://dspace.mediu.edu.my:8181/xmlui/handle/10261/3323Full metadata record
| DC Field | Value | Language |
|---|---|---|
| dc.creator | Real, Gustavo del | - |
| dc.creator | Jiménez Baranda, Sonia | - |
| dc.creator | Mira, Emilia | - |
| dc.creator | Lacalle, Rosa Ana | - |
| dc.creator | Lucas, Pilar | - |
| dc.creator | Gómez-Moutón, Concepción | - |
| dc.creator | Alegret, Marta | - |
| dc.creator | Peña, José María | - |
| dc.creator | Rodríguez Zapata, Manuel | - |
| dc.creator | Álvarez-Mon, Melchor | - |
| dc.creator | Martínez-Alonso, Carlos | - |
| dc.creator | Mañes, Santos | - |
| dc.date | 2008-03-27T08:01:58Z | - |
| dc.date | 2008-03-27T08:01:58Z | - |
| dc.date | 2004-08 | - |
| dc.date.accessioned | 2017-01-31T01:00:57Z | - |
| dc.date.available | 2017-01-31T01:00:57Z | - |
| dc.identifier | The Journal of Experimental Medicine, volume 200, number 4, august 16, 2004, pp. 541–547 | - |
| dc.identifier | 0022-1007 | - |
| dc.identifier | http://hdl.handle.net/10261/3323 | - |
| dc.identifier | doi/10.1084/jem.20040061 | - |
| dc.identifier.uri | http://dspace.mediu.edu.my:8181/xmlui/handle/10261/3323 | - |
| dc.description | Copyright © by The Rockefeller University Press | - |
| dc.description | Human immunodeficiency virus (HIV)-1 infectivity requires actin-dependent clustering of host lipid raft–associated receptors, a process that might be linked to Rho guanosine triphosphatase (GTPase) activation. Rho GTPase activity can be negatively regulated by statins, a family of drugs used to treat hypercholesterolemia in man. Statins mediate inhibition of Rho GTPases by impeding prenylation of small G proteins through blockade of 3-hydroxy-3-methylglutaryl coenzyme A reductase. We show that statins decreased viral load and increased CD4 cell counts in acute infection models and in chronically HIV-1–infected patients. Viral entry and exit was reduced in statin-treated cells, and inhibition was blocked by the addition of l-mevalonate or of geranylgeranylpyrophosphate, but not by cholesterol. Cell treatment with a geranylgeranyl transferase inhibitor, but not a farnesyl transferase inhibitor, specifically inhibited entry of HIV-1– pseudotyped viruses. Statins blocked Rho-A activation induced by HIV-1 binding to target cells, and expression of the dominant negative mutant RhoN19 inhibited HIV-1 envelope fusion with target cell membranes, reducing cell infection rates. We suggest that statins have direct anti–HIV-1 effects by targeting Rho. | - |
| dc.description | Peer reviewed | - |
| dc.format | 861610 bytes | - |
| dc.format | application/pdf | - |
| dc.language | eng | - |
| dc.publisher | Rockefeller University Press | - |
| dc.rights | openAccess | - |
| dc.subject | Cholesterol | - |
| dc.subject | Actin cytoskeleton | - |
| dc.subject | Small GTPases | - |
| dc.subject | Lipid rafts | - |
| dc.subject | Prenylation | - |
| dc.title | Statins Inhibit HIV-1 infection by down-regulating rho activity | - |
| dc.type | Artículo | - |
| Appears in Collections: | Digital Csic | |
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.
